OM:BONEXBiotechs
Assessing Bonesupport Holding (OM:BONEX) Valuation After Mixed Fourth Quarter And Strong Full Year Earnings
Bonesupport Holding (OM:BONEX) recently reported fourth quarter and full year 2025 results, with higher sales and full year net income than the prior year, while quarterly profit and earnings per share softened.
See our latest analysis for Bonesupport Holding.
The latest earnings news comes after a strong run in the share price, with a 1 month share price return of 10.27% and a year to date gain of 14.61%. However, the 1 year total shareholder return shows a decline of 41.85%, which contrasts...